Works matching IS 00070920 AND DT 2022 AND VI 127 AND IP 5


Results: 20
    1
    2
    3

    Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 886, doi. 10.1038/s41416-022-01870-y
    By:
    • Baker, Jennifer L.;
    • Di Meglio, Antonio;
    • Gbenou, Arnauld S.;
    • El Mouhebb, Mayssam;
    • Iyengar, Neil M.;
    • Michiels, Stefan;
    • Cottu, Paul;
    • Lerebours, Florence;
    • Coutant, Charles;
    • Lesur, Anne;
    • Tredan, Oliver;
    • Vanlemmens, Laurence;
    • Jouannaud, Christelle;
    • Hrab, Iona;
    • Everhard, Sibille;
    • Martin, Anne-Laure;
    • Arveux, Patrick;
    • Fabrice, Andre;
    • Vaz-Luis, Ines;
    • Jones, Lee W.
    Publication type:
    Article
    4

    Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide.

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 824, doi. 10.1038/s41416-022-01865-9
    By:
    • Catanzaro, Daniela;
    • Milani, Gloria;
    • Bozza, Angela;
    • Bernardi, Martina;
    • Chieregato, Katia;
    • Menarin, Martina;
    • Merlo, Anna;
    • Celli, Paola;
    • Belli, Romina;
    • Peroni, Daniele;
    • Pozzato, Alessandro;
    • Pozzato, Gianantonio;
    • Raneri, Fabio Angelo;
    • Volpin, Lorenzo;
    • Ruggeri, Marco;
    • Astori, Giuseppe
    Publication type:
    Article
    5

    The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 855, doi. 10.1038/s41416-022-01857-9
    By:
    • Alicandro, Gianfranco;
    • Bertuccio, Paola;
    • Collatuzzo, Giulia;
    • Pelucchi, Claudio;
    • Bonzi, Rossella;
    • Liao, Linda M.;
    • Rabkin, Charles S.;
    • Sinha, Rashmi;
    • Negri, Eva;
    • Dalmartello, Michela;
    • Zaridze, David;
    • Maximovich, Dmitry;
    • Vioque, Jesus;
    • Garcia de la Hera, Manoli;
    • Tsugane, Shoichiro;
    • Hidaka, Akihisa;
    • Hamada, Gerson Shigueaki;
    • López-Carrillo, Lizbeth;
    • Hernández-Ramírez, Raúl Ulises;
    • Malekzadeh, Reza
    Publication type:
    Article
    6

    Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 836, doi. 10.1038/s41416-022-01854-y
    By:
    • Fischer, Laura E.;
    • Stintzing, Sebastian;
    • von Weikersthal, Ludwig Fischer;
    • Modest, Dominik P.;
    • Decker, Thomas;
    • Kiani, Alexander;
    • Kaiser, Florian;
    • Al-Batran, Salah-Eddin;
    • Heintges, Tobias;
    • Lerchenmüller, Christian;
    • Kahl, Christoph;
    • Seipelt, Gernot;
    • Kullmann, Frank;
    • Stauch, Martina;
    • Scheithauer, Werner;
    • Giessen-Jung, Clemens;
    • Uhlig, Jens;
    • Peuser, Bettina;
    • Denzlinger, Claudio;
    • Stahler, Arndt
    Publication type:
    Article
    7

    Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 957, doi. 10.1038/s41416-022-01852-0
    By:
    • Moretto, Roberto;
    • Elliott, Andrew;
    • Rossini, Daniele;
    • Intini, Rossana;
    • Conca, Veronica;
    • Pietrantonio, Filippo;
    • Sartore-Bianchi, Andrea;
    • Antoniotti, Carlotta;
    • Rasola, Cosimo;
    • Scartozzi, Mario;
    • Salati, Massimiliano;
    • Pella, Nicoletta;
    • Calegari, Maria Alessandra;
    • Carullo, Martina;
    • Corti, Francesca;
    • Mauri, Gianluca;
    • Fassan, Matteo;
    • Masi, Gianluca;
    • Brodskiy, Pavel;
    • Lenz, Heinz-Josef
    Publication type:
    Article
    8
    9
    10
    11
    12

    Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 844, doi. 10.1038/s41416-022-01844-0
    By:
    • Menon, Usha;
    • Weller, David;
    • Falborg, Alina Zalounina;
    • Jensen, Henry;
    • Butler, John;
    • Barisic, Andriana;
    • Knudsen, Anne Kari;
    • Bergin, Rebecca J.;
    • Brewster, David H.;
    • Cairnduff, Victoria;
    • Fourkala, Evangelia Ourania;
    • Gavin, Anna T.;
    • Grunfeld, Eva;
    • Harland, Elizabeth;
    • Kalsi, Jatinderpal;
    • Law, Rebecca-Jane;
    • Lin, Yulan;
    • Turner, Donna;
    • Neal, Richard D.;
    • White, Victoria
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.

    Published in:
    British Journal of Cancer, 2022, v. 127, n. 5, p. 908, doi. 10.1038/s41416-022-01806-6
    By:
    • Venn, Nicola C.;
    • Huang, Libby;
    • Hovorková, Lenka;
    • Muskovic, Walter;
    • Wong, Marie;
    • Law, Tamara;
    • Heatley, Susan L.;
    • Khaw, Seong Lin;
    • Revesz, Tom;
    • Dalla Pozza, Luciano;
    • Shaw, Peter J.;
    • Fraser, Chris;
    • Moore, Andrew S.;
    • Cross, Siobhan;
    • Bendak, Katerina;
    • Norris, Murray D.;
    • Henderson, Michelle J.;
    • White, Deborah L.;
    • Cowley, Mark J.;
    • Trahair, Toby N.
    Publication type:
    Article